Showing results (1851-1860 of 4,578) with videos related to
Sort By:
Pageof 458
Experimental Dermatology|November 15, 2013
Topical cholesterol treatment ameliorates hapten-evoked cutaneous hypersensitivity by sustaining expression of 11β-HSD1 in epidermisHiroyuki Murota, Saori Itoi, Mika Terao, et al.Experimental Dermatology|October 30, 2013
Cells or signals: which moves to drive skin pattern formation?Denis HeadonExperimental Dermatology|October 10, 2013
Tumor-educated myeloid cells: impact the micro- and macroenvironmentJürgen C BeckerExperimental Dermatology|October 12, 2013
Molecular imaging reveals time course of matrix metalloproteinase activity in acute cutaneous vasculitis in vivoAnnika Kathrin Steingräber, Sonja Schelhaas, Andreas Faust, et al.Experimental Dermatology|July 25, 2013
Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery diseaseYask Gupta, Steffen Möller, Detlef Zillikens, et al.Experimental Dermatology|July 25, 2013
Characterization of skin-resident T cells using a crawl-out method and flow cytometryJacqueline Poot, Mariëlle Thewissen, Darren Booi, et al.Experimental Dermatology|March 16, 2012
MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loopTobias Sinnberg, Birgit Sauer, Per Holm, et al.Experimental Dermatology|March 16, 2012
Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunctionBritta Hansmann, Kerstin Ahrens, Zhihong Wu, et al.Experimental Dermatology|March 16, 2012
Infrequent p53 gene mutation but UV gradient-like p53 protein positivity in keloidsEllen Heitzer, Hannes Seidl, Isabella Bambach, et al.Experimental Dermatology|March 16, 2012
Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalitiesShinichi Moriwaki, Masahiro Takigawa, Naoya Igarashi, et al.Pageof 458